Page 4 - Danon Disease News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Danon disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Danon Disease Today - Breaking & Trending Today

Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock

CRANBURY, N.J. (BUSINESS WIRE) Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of investigational genetic therapies for rare childhood disorders with high unmet need, announced today that it intends to offer and sell shares of. ....

New York , United States , Kevin Giordano , Syndicate Department , Jp Morgan Securities , Rocket Pharmaceuticals Inc , Morgan Stanley , Morgan Stanley Co , Broadridge Financial Solutions , Exchange Commission , Leerink Partners , Rocket Pharmaceuticals , Lifesci Capital , Island Avenue , Fanconi Anemia , Leukocyte Adhesion Deficiency I , Pyruvate Kinase Deficiency , Danon Disease , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports ,

Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Kevin Giordano , Jp Morgan Securities , Broadridge Financial Solutions , Morgan Stanley Co , Exchange Commission , Syndicate Department , Leerink Partners , Rocket Pharmaceuticals Inc , Morgan Stanley , Lifesci Capital , Island Avenue , Rocket Pharmaceuticals , Fanconi Anemia , Leukocyte Adhesion Deficiency I , Pyruvate Kinase Deficiency , Danon Disease , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports ,

Rocket Pharmaceuticals (RCKT) Prices 7.81M Share Offering at $16/sh

Rocket Pharmaceuticals (RCKT) Prices 7.81M Share Offering at $16/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Kevin Giordano , Leerink Partners , Jp Morgan Securities , Morgan Stanley , Broadridge Financial Solutions , Exchange Commission , Rocket Pharmaceuticals Inc , Syndicate Department , Morgan Stanley Co , Rocket Pharmaceuticals , Lifesci Capital , Island Avenue , Fanconi Anemia , Leukocyte Adhesion Deficiency I , Pyruvate Kinase Deficiency , Danon Disease , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports ,

Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Di

Final alignment reached on a 12 patient, single-arm, open label study with a biomarker based co-primary endpoint assessed at 12 months to support accelerated approvalCo-primary endpoint consisting of LAMP2 protein expression and Left Ventricular (LV) Mass change from baselineCRANBURY, N.J. (BUSINESS WIRE) Rocket P. ....

Kevin Giordano , Gaurav Shah , York Heart Association , Rocket Pharmaceuticals Inc , Drug Administration , Left Ventricular , Rocket Pharmaceuticals , Danon Disease , Biologics Evaluation , Chief Executive Officer , Kansas City Cardiomyopathy Questionnaire , New York Heart Association , Clinical Trial Application , Investigational Medicinal Product Dossier , Fanconi Anemia , Leukocyte Adhesion Deficiency I , Pyruvate Kinase Deficiency , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports ,

Rocket Pharmaceuticals, US FDA Agree on Design of Mid-Stage Trial of Genetic Disorder Drug Candidate

Rocket Pharmaceuticals said Wednesday it has reached an agreement with the US Food and Drug Administration on the design of its phase 2 trial of RP-A501 in Danon Disease, a genetic disorder. ....

Rocket Pharmaceuticals Inc , Rocket Pharmaceuticals , Fanconi Anemia , Leukocyte Adhesion Deficiency I , Pyruvate Kinase Deficiency , Danon Disease ,